Global Point-Of-Care Diagnostics Testing (POCT) Market Study 2016-2026, by Segment (Glucose Monitoring, Cardiac Markers, … …), by Market (Clinics, Home, … …), by Company (Abbott Laboratories, Inc, Abaxis, Inc, … …)
SKU ID :99ST-14635886 | Published Date: 27-Oct-2019 | No. of pages: 63Description
Summary
The global Point-Of-Care Diagnostics Testing (POCT) market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Glucose Monitoring
Cardiac Markers
Infectious Diseases Testing
Cholesterol Testing
Coagulation Monitoring
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Clinics
Home
Laboratories
Assisted living healthcare facilities
Hospitals
Abbott Laboratories, Inc
Abaxis, Inc
Alere, Inc
Bayer AG
Danaher Corporation
Becton, Dickinson And Company
Johnson & Johnson
Nipro Corporation
Roche Diagnostics Limited
Siemens Healthcare
Samsung Medison Co. Ltd
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Point-Of-Care Diagnostics Testing (POCT) market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Glucose Monitoring
Cardiac Markers
Infectious Diseases Testing
Cholesterol Testing
Coagulation Monitoring
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Clinics
Home
Laboratories
Assisted living healthcare facilities
Hospitals
Company Coverage (Sales data, Main Products & Services etc.):
Abbott Laboratories, Inc
Abaxis, Inc
Alere, Inc
Bayer AG
Danaher Corporation
Becton, Dickinson And Company
Johnson & Johnson
Nipro Corporation
Roche Diagnostics Limited
Siemens Healthcare
Samsung Medison Co. Ltd
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now